CD248 and breast cancer: These include enhanced expression of endosialin/TEM-1 in stroma of human colorectal cancer [10, 15], breast cancer [16, 17], histiocytomas [18] and expression directly on tumor cells of mesenchymal origin including sarcoma [19, 20] and melanoma [21, 22].